Torii Pharmaceutical Co Ltd 4551.T-JP:Tokyo Stock Exchange

*Data is delayed | JPY
Last | 3:00 PM JST
2,976.00quote price arrow down-3.00 (-0.10%)
Volume
39,400
52 week range
2,322.00 - 3,270.00
Loading...
  • Open2,959.00
  • Day High2,998.00
  • Day Low2,959.00
  • Prev Close2,979.00
  • 52 Week High3,270.00
  • 52 Week High Date04/28/22
  • 52 Week Low2,322.00
  • 52 Week Low Date07/09/21

Key Stats

  • Market Cap662.84M
  • Shares Out28.09M
  • 10 Day Average Volume42,718.18
  • Dividend48.00
  • Dividend Yield1.61%
  • Beta-
  • YTD % Change3.41

KEY STATS

  • Open2,959.00
  • Day High2,998.00
  • Day Low2,959.00
  • Prev Close2,979.00
  • 52 Week High3,270.00
  • 52 Week High Date04/28/22
  • 52 Week Low2,322.00
  • 52 Week Low Date07/09/21
  • Market Cap662.84M
  • Shares Out28.09M
  • 10 Day Average Volume42,718.18
  • Dividend48.00
  • Dividend Yield1.61%
  • Beta-
  • YTD % Change3.41

RATIOS/PROFITABILITY

  • EPS (TTM)135.20
  • P/E (TTM)22.01
  • Fwd P/E (NTM)-
  • EBITDA (TTM)-
  • ROE (TTM)-
  • Revenue (TTM)-
  • Gross Margin (TTM)-
  • Net Margin (TTM)-
  • Debt To Equity (MRQ)-

EVENTS

  • Earnings Date-
  • Ex Div Date12/29/2021
  • Div Amount24.00
  • Split Date-
  • Split Factor-

Latest On Torii Pharmaceutical Co Ltd

There is no recent news for this security.

Content From Our Affiliates

There is no recent news for this security.

Profile

MORE
TORII PHARMACEUTICAL CO., LTD. is mainly engaged in the manufacture and sale of pharmaceutical products. The Company’s main product categories include oral pruritus improving agents, proteolytic enzyme inhibitors, hyperkalemia improving agents, topical adrenocortical hormones, allergen immunotherapy for cedar pollinosis, allergen immunotherapy for mite allergy, active viable bacterial preparations, uterine contraction inhibitors in premature birth and others. The Company’s...
Goichi Matsuda
President, Chief Executive Officer, Representative Director
Address
Torii Nihombashi Bldg.
3-4-1, Nihombashi Hon-cho
Chuo-ku, TKY
103-8439
Japan